Monitoring bone resorption in early postmenopausal women by an immunoassay for cross‐linked collagen peptides in urine

Journal of Bone and Mineral Research

Volumn 9, Issue 2, 1994, Pages 135-142

  Gertz, B J ^a   Shao, P ^b   Hanson, D A ^b   Quan, H ^a   Harris, S T ^c   Genant, H K ^c   Chesnut, C H ^b   Eyre, D R ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; BONE TURNOVER; CALCIUM URINE LEVEL; CLINICAL TRIAL; CROSS LINKING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE; URINARY EXCRETION;

ALENDRONATE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CALCIUM; DIPHOSPHONATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYDROXYPROLINE; LUMBAR VERTEBRAE; MIDDLE AGE; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDE FRAGMENTS; PROCOLLAGEN; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T;

EID: 0028009221     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.5650090202     Document Type: Article

References (29)

1. Diagnostic procedures in disorders of calcium metabolism
2. Diagnostic evaluation of osteoporosis
3. Biochemical markers of bone turnover: Methodology and clinical use in osteoporosis
4. New biomarkers of bone resorption (editorial)
5. Procollagen type I carboxy terminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase
6. Cross‐link maturation in bone collagen
7. Urinary excretion of pyridinium cross‐links: A new marker of bone resorption in metabolic bone disease
8. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross‐links
9. Urinary excretion of pyridinoline cross‐links correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis
10. Urinary hydroxypyridinium crosslinks of collagen in primary hyperparathyroidism
11. Marked diurnal variation in urinary excretion of pyridinium cross‐links in premenopausal women
12. Urinary excretion of pyridinoline and deoxypridinoline: Circadian rhythm
13. Total 24‐hour pyridinium cross‐link excretion correlates with cancellous bone resorption rate
14. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis
15. Urinary pyridinium cross‐links of collagen
16. Urinary pyridinium cross‐links as markers of bone resorption in tumor‐associated hypercalcemia
17. A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross‐linked N‐telopeptides in urine
18. The effect of short‐term treatment with alendronate upon vertebral density and biochemical markers of bone remodeling in early postmenopausal women
19. Quantitation of hydroxypyridinium cross‐links in collagen by high performance liquid chromatography
20. A simplified method for the estimation of urinary total hydroxyproline
21. Collagen cross‐linking amino acids
22. Effects of transdermal estrogen replacement on parathyroid hormone secretion
23. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose‐response relationships in early postmenopausal women
24. Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross‐links: A longitudinal and cross‐sectional study
25. Urinary total hydroxyproline measured by HPLC: Comparison of spot and timed urine collections
26. Estrogen protection against bone resorbing effects of parathyroid hormone infusion
27. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12‐year study